Breast cancer screen

Life-extending breast cancer drug to benefit thousands after NICE approval

The National Institute for Health and Care Excellence (NICE) have approved another potentially life-extending breast cancer treatment, after final draft guidance was published today.

The drug combination of palbociclib and fulvestrant has been recommended for adults with the advanced breast cancer called HER2-, who have already undergone hormone therapy.

Palbociclib is a pill taken once a day and is a type of drug known as a cyclin-dependent kinase 4 and 6 inhibitor. These drugs work by inhibiting proteins in cancer cells, ultimately depriving them of the ability to divide and therefore grow and spread.

Palbociclib has been available via the Cancer Drugs Fund (CDF) since 2020 whilst more evidence was collated to address concerns about how cost-efficient it was and how long it increases a patient’s life expectancy.

Helen Knight, interim director of medicines evaluation at NICE, said: who have already had endocrine treatment. It provides a further valuable treatment option that can increase the time they remain in good health, and to delay the need for chemotherapy and its associated side-effects.

“It is further proof of the success of the Cancer Drugs Fund in giving tens of thousands of patients early access to promising new cancer treatments while more evidence is gathered on their clinical and cost-effectiveness.

“As our evaluation of palbociclib shows, this process works well when companies engage with NICE and NHS England to price their medicines reasonably and present a clear case for additional evidence to be gathered while they’re in the CDF.”

The recommendation means that the drug combination will now be available for routine use on the NHS. Palbociclib is just one of 16 breast cancer treatments approved by NICE since 2018 – actions that have benefited tens of thousands of people.

NHE Nov/Dec 2023

NHE Nov/Dec 2023

AI is key in helping dementia patients live independently for longer.

The Nov/Dec 2023 edition of NHE brings you expert comment and analysis on a range of key health sector topics, from digital transformation to navigating post-pandemic challenges.

Videos...

View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Events

NHE has created a full calendar of events to address the most important issues that influence the delivery of healthcare services. Over 365 days you'll have the opportunity to hear from a range of highly motivating, informative and inspirational speakers. These speakers will equip you with the knowledge and unique insight to enable you to overcome the challenges that you face.

National Health Executive Podcast

Ep 39.
What makes a good NHS manager? with Anthony Painter, Director of Policy at Chartered Management Institute (CMI)

In episode 39 of the National Health Executive podcast, we were joined by Anthony Painter, who is the director of policy at the Chartered Management Institute (CMI), to discuss all things management within the UK health sector and NHS.
 

During the podcast, Anthony shared some of the recent research CMI conducted in partnership with the Social Market Foundation, which centred around the state of management and leadership within the NHS.

More articles...

View all